Get the Stockscreener App
0.00
2.62%
17.97
After Hours:
19.90
19.90
+
Defiance Trillion Dollar Club Index Etf stock is traded at $0.00, with a volume of 0.
It is up +2.62% in the last 24 hours and up +2.67% over the past month.
See More
Previous Close:
$17.97
Open:
$0
24h Volume:
0
Relative Volume:
Market Cap:
$N/A
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
0.00
EPS:
0.62
Net Cash Flow:
-
1W Performance:
+0.00%
1M Performance:
+2.67%
6M Performance:
+137.32%
1Y Performance:
+6.04%
1-Day Range:
$0.00
$0.00
1-Week Range:
$0.00
$0.00
52-Week Range:
$0.00
$0.00
Defiance Trillion Dollar Club Index Etf Stock (TRIL) Company Profile
Name
Defiance Trillion Dollar Club Index Etf
Sector
Industry
Phone
-
Address
-
Compare TRIL vs VTI, SPY, IVV, VB, QQQ
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TRIL
Defiance Trillion Dollar Club Index Etf
|
0.00 | 0 | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
335.73 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
State Street Spdr S P 500 Etf Trust
|
680.33 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
683.37 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
274.02 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
601.58 | 124.43B | 0 | 0 | 0 | 0.00 |
Defiance Trillion Dollar Club Index Etf Stock (TRIL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-17-21 | Downgrade | The Benchmark Company | Buy → Hold |
| Apr-14-21 | Initiated | The Benchmark Company | Buy |
| Oct-12-20 | Initiated | Evercore ISI | Outperform |
| Sep-10-20 | Upgrade | H.C. Wainwright | Neutral → Buy |
| Aug-17-20 | Initiated | Craig Hallum | Buy |
| Jun-19-20 | Initiated | Oppenheimer | Outperform |
| May-26-20 | Initiated | JMP Securities | Mkt Outperform |
| Apr-13-18 | Resumed | Leerink Partners | Mkt Perform |
| Jul-17-17 | Initiated | H.C. Wainwright | Buy |
| Aug-03-16 | Initiated | Ladenburg Thalmann | Buy |
| May-15-15 | Initiated | Oppenheimer | Outperform |
| Apr-27-15 | Initiated | Leerink Partners | Outperform |
View All
Defiance Trillion Dollar Club Index Etf Stock (TRIL) Latest News
PA Daily | Coinbase CEO denies White House will withdraw support for the CLARITY Act; Bitcoin spot ETF sees net inflows of $1.42 billion this week. - 富途牛牛
Defiance ETFs Announces Closure of Select Funds - The Manila Times
Defiance Trillion Dollar Club Index ETF (TRIL) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
ETF Prime: Murphy on the New Faces of the ETF Boom - ETF Database
ETF Trades: What Has and Hasn’t Worked in 2025ETF Prime with Nate GeraciPodcasts - Advisor Perspectives
TRIL ETF Holdings List — BOATS:TRIL - TradingView
Defiance floats ETF tied to firms, digital assets valued above US$1 trillion - Structured Retail Products
TRIL Stock Fund Price and Chart — BOATS:TRIL - TradingView — Track All Markets
US ETF launches from 25th September to 2nd October, 2025 - ETF Express
‘$1 Trillion Club’ ETF Offers Investors Exposure to Tech Giants and Bitcoin - The Currency analytics
Defiance Trillion Dollar Club Index ETF (NASDAQ: TRIL)Share Price - intelligentinvestor.com.au
A new "Trillion Dollar" ETF based on stocks and Bitcoin has appeared in the US. - Happy Coin News
'$1T Club' ETF offers exposure to tech giants and Bitcoin - Bitget
Tron Inc. Shares Tumble 85% From June Peak Amid DAT Market Slump - Decrypt
Defiance ETFs Launches New Trillion-Dollar Assets ETF: U.S. Access to Tech Giants and Crypto-Linked Plays - Blockchain News
SEC No-Action Letter Creates Opening for More Firms to Serve as Crypto Custodians - Decrypt
Ripple CTO David Schwartz to Step Back, Remain on Board as CTO Emeritus - Decrypt
'$1 Trillion Club' ETF Gives Investors Exposure to Tech Giants—And Bitcoin - Decrypt
Defiance Launches $TRIL – The Trillion Dollar Club ETF: The New “Magnificent 7” of Global Markets - GlobeNewswire
TRIL ETF Analysis: Dividends, Returns NASDAQ:TRIL - TradingView — Track All Markets
Defiance Launches JEDI – Drone & Modern Warfare ETF: Exposure to Leading Drone and Modern Warfare Companies - GlobeNewswire
Defiance ETFs Launches QLDY, the First ETF to Pay Distributions Twice Weekly * - GlobeNewswire
Defiance’s QTUM – Quantum Computing ETFSurpasses $2 - GlobeNewswire
Sezary Syndrome Clinical Trials, Companies, Therapeutic Assessment, Therapies, Treatment Algorithm, Pipeline | 4SC AG, Seagen Inc., Merck Sharp & Dohme Corp., Innate Pharma, Trillium Therapeutics, Sec - Barchart.com
Defiance ETFs Launches Leveraged + Income ETFs for AMD (AMDU) and Super Micro Computer (SMCC) - GlobeNewswire
Defiance ETFs Launches Leveraged + Income ETFs for Palantir - GlobeNewswire
Defiance Launches VIXI: Enhanced Long Volatility ETF with Leveraged Short S&P 500 Exposure - GlobeNewswire
Defiance Launches AIPO: The First ETF Focused on AI Power Infrastructure - GlobeNewswire
Weekly ETF Industry Recap: U.S., Europe, and Canada Highlights – July 7-July 11, 2025 - Trackinsight
Pfizer ends Phase 1b/2 trial for final Trillium CD47 drug - Endpoints News
Defiance ETFs Unveils $MST: The First Leveraged MicroStrategy ETF that Seeks to Pay Income Weekly - GlobeNewswire
Defiance Launches $GLDY, Gold Enhanced Options Income ETF - GlobeNewswire
Defiance’s XMAG ETF Outshines S&P 500 Amid “Magnificent 7” - GlobeNewswire
Defiance ETFs' QTUM, Quantum Computing ETF, Earns 5-Star Morningstar Rating and Surpasses $1 Billion in AUM - GlobeNewswire
CD47 Antigen Inhibitors Clinical Trial Pipeline Insights Featuring 20+ Companies | DelveInsight - GlobeNewswire
$QTUM, Defiance Quantum Computing ETF, Surpasses $1 Billion in AUM - GlobeNewswire
Defiance Launches XMAG The First ETF Offering Exposure to the S&P 500 Excluding the “Magnificent 7” Tech Giants - GlobeNewswire
Defiance ETFs Announces Monthly Distributions on $QQQY - GlobeNewswire
GlobeNewswire by Notified - The Manila Times
Quell Therapeutics Appoints Experienced Biopharma Leader - GlobeNewswire
Genexine, EPD Biotherapeutics to merge for new protein degraders - BioWorld MedTech
Pension plans still AWOL as Canadian life-sciences venture capital firms re-up for latest funds - The Globe and Mail
Pfizer to acquire Trillium in $2.3bn deal - BioProcess International
Ratio Therapeutics Announces $50M Series B Financing to Advance Targeted Radiotherapies for Cancer Treatment - PR Newswire
Ozempic maker Novo Nordisk bulks up on weight loss drugs, buying Montreal’s Inversago for $1-billion - The Globe and Mail
Bellus shareholders approve US$2-billion takeover by GSK; deal set to close this month - The Globe and Mail
Novartis buys Chinook for US$3.2-billion, latest in string of big exits for Canadian biotechs - The Globe and Mail
GSK’s $2-billion purchase of Bellus delivers second big exit for Montreal’s Bellini family - The Globe and Mail
Jan Skvarka, former Trillium CEO, on Driving a Turnaround - Timmerman Report
Zentalis Pharmaceuticals Appoints Dr. Jan Skvarka to its Board of Directors - citybiz
Autobahn Therapeutics raises funds to advance ABX-002 for treatment-resistant depression - BioWorld MedTech
Defiance Trillion Dollar Club Index Etf Stock (TRIL) Financials Data
There is no financial data for Defiance Trillion Dollar Club Index Etf (TRIL). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
1.23%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):